Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TMJ Diagnostic Devices Require 510(k) Clearance, Clinical Data – FDA Rule

This article was originally published in The Gray Sheet

Executive Summary

FDA's 11proposed rule on jaw-tracking and dental sonography devices interpreting temporomandibular joint positions or sounds will pave the way for firms to market the products for diagnosing TMJ disorder and associated orofacial pain

You may also be interested in...



Sonogram, Kinesiograph TMD Devices Should Be Class I With 510(k) -Panel

Sonogram and kinesiograph temporomandibular joint (TMJ) devices should be classified as Class I, but are of sufficient concern to warrant submission of a 510(k), FDA's Dental Products Panel unanimously recommended (7-0) at an Aug. 5 meeting.

ELECTROMYOGRAPHS USED IN DIAGNOSING TEMPOROMANDIBULAR DISORDERS

ELECTROMYOGRAPHS USED IN DIAGNOSING TEMPOROMANDIBULAR DISORDERS should be Class III devices, FDA's Dental Products Panel unanimously recommended at an Oct. 13 meeting in Gaithersburg, Maryland. The panel voted 8-0 to recommend that the agency put the devices in Class III and make the call for premarket approval applications on the devices a high priority.

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017038

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel